Literature DB >> 31240404

Home Blood Pressure Monitoring in Children and Adolescents: Systematic Review of Evidence on Clinical Utility.

George Stergiou1, Emelina Stambolliu2, Ioanna Bountzona2, Angeliki Ntineri2, Anastasios Kollias2, Andriani Vazeou3, Alexandra Soldatou4.   

Abstract

PURPOSE OF REVIEW: For the accurate diagnosis and management of hypertension, out-of-office blood pressure evaluation using ambulatory (ABPM) or home monitoring (HBPM) is currently recommended. In children, there is considerable evidence on the clinical utility of ABPM, whereas the evidence on HBPM is limited. This systematic review presents (i) the benefits of HBPM in children; (ii) the evidence on normal range, diagnostic accuracy, and relationship with preclinical organ damage; and (iii) guidance for devices, monitoring schedule, and interpretation. RECENT
FINDINGS: HBPM is a useful adjunct to the conventional office measurements for the evaluation of children with suspected or treated hypertension. HBPM is feasible in children and has good reproducibility, diagnostic accuracy and acceptability by users, and relatively low cost. Thus, it has greater potential for widespread and long-term use than ABPM, which is more expensive and often not available or not tolerated. Automated monitors that have been clinically validated specifically in children should be used with appropriate cuff size. HBPM for 7 days (minimum 3) with duplicate morning and evening measurements (minimum 12 readings) should be performed in children with suspected or treated hypertension before each office visit. Until more data become available, in case of diagnostic disagreement between office blood pressure and HBPM, treatment decisions should be based on ABPM. HBPM is clinically useful in children with hypertension. More research is needed on its clinical application, and more automated devices need to be clinically validated in this population.

Entities:  

Keywords:  Ambulatory blood pressure monitoring; Diagnosis; Masked hypertension; Out of office; Self-measurement; White coat hypertension

Mesh:

Year:  2019        PMID: 31240404     DOI: 10.1007/s11906-019-0967-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  50 in total

1.  Changes of blood pressure and left ventricular mass in pediatric renal transplantation.

Authors:  Erwin Kitzmueller; Andreas Vécsei; Judith Pichler; Michael Böhm; Thomas Müller; Regina Vargha; Dagmar Csaicsich; Christoph Aufricht
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

2.  Home blood pressure monitoring in diabetes.

Authors:  C Gompels; D Savage
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

3.  Reproducibility of home and ambulatory blood pressure in children and adolescents.

Authors:  George S Stergiou; Christina V Alamara; Eleanna V Salgami; Iraklis N Vaindirlis; Catherine Dacou-Voutetakis; Theodore D Mountokalakis
Journal:  Blood Press Monit       Date:  2005-06       Impact factor: 1.444

4.  Prevalence, persistence, and clinical significance of masked hypertension in youth.

Authors:  Empar Lurbe; Isabel Torro; Vicente Alvarez; Tim Nawrot; Rafael Paya; Josep Redon; Jan A Staessen
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

5.  How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists.

Authors:  Robert P Woroniecki; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2005-04-05       Impact factor: 3.714

6.  Measurement of blood pressure at home: survey among pediatric nephrologists.

Authors:  M Bald; P F Hoyer
Journal:  Pediatr Nephrol       Date:  2001-12       Impact factor: 3.714

7.  Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy.

Authors:  George S Stergiou; Nikolaos M Baibas; Alexandra P Gantzarou; Irini I Skeva; Chrysa B Kalkana; Leonidas G Roussias; Theodore D Mountokalakis
Journal:  Am J Hypertens       Date:  2002-02       Impact factor: 2.689

8.  Out-of-office blood pressure in children and adolescents: disparate findings by using home or ambulatory monitoring.

Authors:  George S Stergiou; Christina V Alamara; Chrysa B Kalkana; Iraklis N Vaindirlis; Constantinos J Stefanidis; Catherine Dacou-Voutetakis; Theodore D Mountokalakis
Journal:  Am J Hypertens       Date:  2004-10       Impact factor: 2.689

9.  Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes.

Authors:  Empar Lurbe; Josep Redon; Ajit Kesani; Jose Maria Pascual; Jose Tacons; Vicente Alvarez; Daniel Batlle
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

10.  Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure.

Authors:  Elke Wühl; Charlotte Hadtstein; Otto Mehls; Franz Schaefer
Journal:  Pediatr Res       Date:  2003-11-19       Impact factor: 3.756

View more
  3 in total

Review 1.  High Blood Pressure in Children and Adolescents: Current Perspectives and Strategies to Improve Future Kidney and Cardiovascular Health.

Authors:  Cal H Robinson; Rahul Chanchlani
Journal:  Kidney Int Rep       Date:  2022-03-01

2.  Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Experts Coordinated by the French Society of Hypertension.

Authors:  Béatrice Bouhanick; Philippe Sosner; Karine Brochard; Claire Mounier-Véhier; Geneviève Plu-Bureau; Sébastien Hascoet; Bruno Ranchin; Christine Pietrement; Laetitia Martinerie; Jean Marc Boivin; Jean Pierre Fauvel; Justine Bacchetta
Journal:  Front Pediatr       Date:  2021-07-07       Impact factor: 3.418

3.  Discrepancies in the diagnosis of hypertension in adolescents according to available office and home high blood pressure criteria.

Authors:  Fabiana G A M Feitosa; Audes D M Feitosa; Marco A Mota-Gomes; Annelise M G Paiva; Weimar S Barroso; Roberto D Miranda; Eduardo C D Barbosa; Andréa A Brandão; Thiago S V Jardim; Paulo C B V Jardim; Arthur B M Feitosa; Maria V C Santos; José L Lima-Filho; Andrei C Sposito; Wilson Nadruz
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-12-09       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.